Gold-Catalyzed Formal (3+2) Cycloaddition in an Ionic Liquid: Environmentally Friendly and Stereoselective Synthesis of Polysubstituted Indanes from Benzylic Alcohols and 1-Phenylpropenes
Synlett · 01.06.2023 · 34 (09) · 1068-1074
DOI: 10.1055/a-2002-4122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 01.06.2023. Verfasst von Nobuyoshi Morita und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
A gold-catalyzed formal (3+2) cycloaddition of benzylic alcohols with 1-phenylpropenes in an ionic liquid permits the environmentally friendly stereoselective synthesis of polysubstituted indanes in good yields and with high selectivity. The gold catalyst can be recycled at least five times.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Morita, N., Tamura, O., Chiaki, H., Ikeda, K., Tanaka, K., & Hashimoto, Y. (2023). Gold-Catalyzed Formal (3+2) Cycloaddition in an Ionic Liquid: Environmentally Friendly and Stereoselective Synthesis of Polysubstituted Indanes from Benzylic Alcohols and 1-Phenylpropenes. Synlett, 34(09), 1068-1074. https://doi.org/10.1055/a-2002-4122
Vancouver
Morita N, Tamura O, Chiaki H, Ikeda K, Tanaka K, Hashimoto Y. Gold-Catalyzed Formal (3+2) Cycloaddition in an Ionic Liquid: Environmentally Friendly and Stereoselective Synthesis of Polysubstituted Indanes from Benzylic Alcohols and 1-Phenylpropenes. Synlett. 2023;34(09):1068-1074. doi:10.1055/a-2002-4122
BibTeX
@article{Morita2023,
author = {Morita, Nobuyoshi and Tamura, Osamu and Chiaki, Hitomi and Ikeda, Kanae and Tanaka, Kosaku and Hashimoto, Yoshimitsu},
title = {Gold-Catalyzed Formal (3+2) Cycloaddition in an Ionic Liquid: Environmentally Friendly and Stereoselective Synthesis of Polysubstituted Indanes from Benzylic Alcohols and 1-Phenylpropenes},
journal = {Synlett},
year = {2023},
volume = {34},
number = {09},
pages = {1068--1074},
doi = {10.1055/a-2002-4122}
}
EUVIMED